These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3893007)

  • 21. Prospective clinical trial of human growth hormone in short children without growth hormone deficiency.
    Gertner JM; Genel M; Gianfredi SP; Hintz RL; Rosenfeld RG; Tamborlane WV; Wilson DM
    J Pediatr; 1984 Feb; 104(2):172-6. PubMed ID: 6363657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
    Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
    J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents.
    Moore DC; Ruvalcaba RH; Smith EK; Kelley VC
    Horm Res; 1982; 16(1):49-55. PubMed ID: 7200069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factors I and II in evaluation of growth retardation.
    Rosenfeld RG; Wilson DM; Lee PD; Hintz RL
    J Pediatr; 1986 Sep; 109(3):428-33. PubMed ID: 3746530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth and somatomedin responses to growth hormone in Down's syndrome.
    Annerén G; Sara VR; Hall K; Tuvemo T
    Arch Dis Child; 1986 Jan; 61(1):48-52. PubMed ID: 2937371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children.
    Christiansen JS; Orskov H; Binder C; Kastrup KW
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):6-10. PubMed ID: 6681687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism.
    Grunt JA; Howard CP; Daughaday WH
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):168-74. PubMed ID: 6539552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels.
    Albertsson-Wikland K; Hall K
    J Clin Endocrinol Metab; 1987 Oct; 65(4):671-8. PubMed ID: 3654912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL; Daughaday WH; Weldon VV
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G; Izzo G; La Montagna G; Bellastella A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The short child with subnormal plasma somatomedin C.
    Rudman D; Kutner MH; Chawla RK
    Pediatr Res; 1985 Oct; 19(10):975-80. PubMed ID: 4058978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatomedin-C/insulin-like growth factor-I as a modulator of growth during childhood and adolescence.
    Furlanetto RW; Cara JF
    Horm Res; 1986; 24(2-3):177-84. PubMed ID: 3530940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
    Jørgensen JO; Møller N; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jan; 70(1):207-14. PubMed ID: 2294131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian rhythm in plasma immunoreactive somatomedin-C in children.
    Nicolau GY; Haus E; Lakatua D; Plîngă L; Sackett-Lundeen L; Berg H; Ungureanu E; Petrescu E
    Endocrinologie; 1985; 23(2):97-103. PubMed ID: 4041074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K; Hizuka N; Shizume K; Honda N; Ling NC
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired refractoriness to growth hormone in a patient with isolated growth hormone deficiency: growth and plasma somatomedin-C response to high-dose growth hormone therapy.
    Winterer J; Chrousos G; Cassorla F; Loriaux DL
    J Pediatr; 1984 Jun; 104(6):908-11. PubMed ID: 6539376
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical application of serum somatomedin determination].
    Pertzelan A; Kowadlo-Silbergeld A; Mameat R; Nevo Z; Laron Z
    Harefuah; 1979 May; 96(9):519-21. PubMed ID: 520926
    [No Abstract]   [Full Text] [Related]  

  • 39. Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone.
    Florini JR; Prinz PN; Vitiello MV; Hintz RL
    J Gerontol; 1985 Jan; 40(1):2-7. PubMed ID: 4038409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of human growth hormone injection frequency on linear growth rate.
    Albertsson-Wikland K
    Acta Paediatr Scand Suppl; 1987; 337():110-6. PubMed ID: 3481175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.